{"doi":"10.1016/j.ejim.2023.02.014","title":"Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe","abstract":null,"journal":"European Journal of Internal Medicine","year":2023,"id":644502,"datarank":0.3574036600320788,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.14945950586409515,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.14945950586409515,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":3,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1677605,"name":"Victoria Manzano-Gamero","orcid":null,"position":1,"is_corresponding":false},{"id":1677606,"name":"Juan de Dios Luna","orcid":null,"position":2,"is_corresponding":false},{"id":1677603,"name":"Alfredo Jose Pardo-Cabello","orcid":"0000-0003-2287-3067","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe","abstract":"The current pandemic of coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) prompted the rapid production of vaccines against the virus. In view of the seriousness of the situation, the European Medicines Agency (EMA) quickly approved several COVID-19 vaccines: the tozinameran mRNA (produced by Pfizer-BioNTech), the CX-024414 mRNA (by Moderna), the chimpanzee adenoviral vector CHADOX1 NCOV-19 (by AstraZeneca), and the adenoviral vector type 26 AD26.COV2.S (by Janssen).","is_dataset_classified":null,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36792428","pmcid":"PMC9922576","openalex_id":"https://openalex.org/W4320498525","authors":[],"funders":[],"total_grants":0,"fwci":0.5074,"citation_percentile":0.59363945,"influential_citations":0,"citation_trend":[{"year":2023,"count":2},{"year":2024,"count":1}],"oa_status":"hybrid","license":"public-domain","oa_locations":[{"url":"http://www.ejinme.com/article/S0953620523000523/pdf","host_type":"journal"},{"url":"http://www.ejinme.com/article/S0953620523000523/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0953620523000523?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0953620523000523?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.ejim.2023.02.014","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36792428","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9922576","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9922576/pdf/main.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9922576","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9922576?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["SARS-CoV-2 and COVID-19 Research","Heparin-Induced Thrombocytopenia and Thrombosis","Pharmacovigilance and Adverse Drug Reactions","Humans","COVID-19 Vaccines","COVID-19","Vaccines","Drug-Related Side Effects and Adverse Reactions","Europe","Vaccination"],"mesh_terms":["COVID-19","COVID-19 Vaccines","Europe","Humans","Vaccination","Vaccines","Drug-Related Side Effects and Adverse Reactions"],"keywords":["Medicine","Pharmacovigilance","Adverse effect","European union","Rash","Hydroxychloroquine","Immunology","Coronavirus disease 2019 (COVID-19)","Dermatology","Internal medicine","Disease","Infectious disease (medical specialty)","Adverse drug reaction","Covid-19 Vaccines","Chadox1 Ncov-19","Tozinameran","Ad26covs1","Cx-024414"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-09T01:18:55.071969Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}